Get started
Author

E. Casado

Observed names: Casado E, Casado Sáenz, Enrique, Casado, E., Casado, Enrique, E Casado, E Casado Burgos, E. Casado Burgos, ENRIQUE CASADO, Enrique Casado, Enrique Casado Burgos
Observed institutions: Universitat Autònoma de Barcelona, Queen Elizabeth Hospital, Corporació Sanitària Parc Taulí, Hospital Del Mar, Hospital de Sant Joan Despí Moisès Broggi, Institute of Research and Innovation Parc Tauli, Hospital Universitari Germans Trias i Pujol, Hull York Medical School
ORCID: 0000-0001-8839-6430
Observed ORCID: 0000-0001-8839-6430
OpenAlex ID: A5014139019
Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients
2005 · E Casado, J Gratacós, et al. · Annals of the Rheumatic Diseases · 151
PDF
Vitamin D supplementation and COVID-19 risk: a population-based, cohort study
2021 · J. Oristrell, J. C. Oliva, et al. · Journal of Endocrinological Investigation · 129
PDF
Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial
2018 · Piet Geusens, Fernando Marin, et al. · Journal of Bone and Mineral Research · 114
PDF
FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort
2012 · Rafael Azagra, Genís Roca, et al. · BMC Musculoskeletal Disorders · 89
PDF
Recomendaciones de la Sociedad Española de Reumatología sobre osteoporosis
2018 · Antonio Naranjo Hernández, Petra Díaz del Campo Fontecha, et al. · Reumatología Clínica · 76
Sexual dysfunction in fibromyalgia patients.
2008 · C Orellana, E Casado, et al. · PubMed · 60
Hypovitaminosis D as a risk factor of hip fracture severity
2011 · M. Larrosa, A. Gomez, et al. · Osteoporosis International · 59
Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate
2006 · J Gratacós, E Casado, et al. · Annals of the Rheumatic Diseases · 56
Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
2001 · E Casado, A Olivé, et al. · PubMed · 49
Umbrales de FRAX® para identificar personas con alto o bajo riesgo de fractura osteoporótica en población femenina española
2014 · Rafael Azagra, Genís Roca, et al. · Medicina Clínica · 47
Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX ™ tool in Spain
2011 · Rafael Azagra, Genís Roca, et al. · BMC Musculoskeletal Disorders · 45
PDF
Secular trend in the incidence of hip fracture in Catalonia, Spain, 2003–2014
2016 · Maria-Jesús Pueyo-Sánchez, Marta Larrosa, et al. · Age and Ageing · 37
PDF
Reference intervals for bone turnover markers in Spanish premenopausal women
2015 · Núria Guañabens, Xavier Filella, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 37
PDF
Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-Based Study
2021 · Joaquim Oristrell, Joan C. Oliva, et al. · Biomedicines · 34
PDF
The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment
2019 · SEIOMM Working Group, Núria Guañabens, et al. · Endocrine · 33
Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts
2020 · T. Thomas, E. Casado, et al. · Osteoporosis International · 31
PDF
Utilidad de la herramienta FRAX en el tratamiento de la osteoporosis en población femenina española
2011 · Rafael Azagra Ledesma, Daniel Prieto-Alhambra, et al. · Medicina Clínica · 28
Novel formulations of oral bisphosphonates in the treatment of osteoporosis
2022 · Nicholas Fuggle, Nasser Al-Daghri, et al. · Aging Clinical and Experimental Research · 27
PDF
Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial
2020 · J.-J. Body, F. Marin, et al. · Osteoporosis International · 27
PDF
Recommendations by the Spanish Society of Rheumatology on Osteoporosis
2019 · Antonio Naranjo Hernández, Petra Díaz del Campo Fontecha, et al. · Reumatología Clínica (English Edition) · 27
Fracture experience among participants from the FROCAT study: what thresholding is appropriate using the FRAX tool?
2015 · R. Azagra, M. Zwart, et al. · Maturitas · 25
Recomendaciones de la SEIOMM en la prevención y tratamiento del déficit de vitamina D
2021 · Casado Sáenz, Enrique, Quesada Gómez, José Manuel, et al. · ABACUS. Repositorio de Producción Científica (Universidad Europea) · 24
Parathyroid hormone receptor agonists in the management of osteoporosis
2025 · Nicholas Fuggle, René Rizzoli, et al. · Nature Reviews Rheumatology · 23
Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy
2021 · Enrique Casado, Angel Borque-Fernando, et al. · The World Journal of Men s Health · 22
PDF
Comparison of total, free and bioavailable 25-OH vitamin D determinations to evaluate its biological activity in healthy adults: the LabOscat study
2017 · LabOscat Study Group, P. Peris, et al. · Osteoporosis International · 22
Works count: 142
Citation count: 1,681
H-index: 23
I10-index: 42
Year
Topic
Type